Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Pest Control Innovator SenesTech Inc. (NASDAQ: SNES) Offers Unique Solution to Tackle the Spread of Rats Amid Growing Health Concerns

  • SenesTech Inc. is building worldwide influence as a rat population control solution that humanely and cost-effectively based on fertility control
  • The company’s trademarked ContraPest(R) brand is designed to target rat pest populations large and small, as well as hard-to-get roof rodents, and is the only EPA-registered rat contraception product for both male and female rats
  • The rebound in rat populations worldwide in the wake of the COVID pandemic and a recent report on the spread of the rat lungworm parasite (which can sicken or kill humans) have fostered a new sense of concern about rat-carried diseases
  • SenesTech is expanding its international presence, with new client agreements this summer in The Maldives and South Africa. Additional discussions are underway in South America and Asia

Controlling rat populations and the diseases associated with them has been a concern for centuries, underlined in the public consciousness by historical plagues believed to be spread by rats, including the 14th century “Black Death” that remains the most fatal pandemic recorded in human history, causing the deaths of 75–200 million people (

In the modern era, rat populations are rebounding in the wake of the COVID pandemic ( and in tandem with global climate change (, leading afflicted municipal authorities to seek creative solutions for coping with them. Some have proved humorous — Paris’ mayor recently drew snickers for rewriting its “anti-rat plan” with the establishment of a rat-coexistence “committee on the question of cohabitation” (, while New Yorkers are drawing attention to their pestilence through a booming new “rat tourism” market ( for people who cheer the rodents’ squeaks and squeals.

But the potential for deadly and debilitating diseases spread by rats remains a worry for the general population. A small study describing the advancing spread of rat lungworm, a parasite that can ultimately infect humans, into a new area of the southeastern United States ( spawned news media headlines this past month such as “Worm that jumps from rats to slugs to human brains has invaded Southeast US” (

Rodent control innovator SenesTech (NASDAQ: SNES) is spreading its clean-cities solution for stopping the growth of rat populations through agreements with government and industry partners around the world, which in recent months have included officials in Washington and California (, the Maldives ( and South Africa (

SenesTech’s trademarked ContraPest(R) brand has the distinction of being the only EPA-registered birth control for male and female rats, which simply limits the enormous (tens of thousands per year) pupping rate of the rodents. The company serves governmental integrated pest management (“IPM”) programs as well as individual customers seeking smaller-scale solutions.

ContraPest has been shown to reduce rat activity over 90 percent in IPM programs (, with varied formulations designed to target problem areas based on size and location (such as if an above-ground, roof area solution is needed).

The costs of rat infestation can be enormous for afflicted businesses. One poultry farm reported losing up to $500,000 per year just in feed taken by rodents it had failed to control despite varied efforts. After the Florida company was introduced to Contra Pest, it reported reduced feed loss and an 88 percent recovery from pullet loss due to predation (

“When we introduced ContraPest, we needed to convince the pest control market of two things: the value of fertility control, and the applicability of a liquid bait into their procedures,” SenesTech President and CEO Joel Fruendt stated in a July news release ( “With continued revenue growth, new product introductions, expanded sales and distribution agreements, and a keen focus on operational improvements to drive the business towards profitability, I believe we made good progress over the past quarter. With 126% sales growth during the month of July 2023, I believe we are well positioned for a strong second half of the year.”

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published:

Los Angeles, CA
310.299.1717 Office
[email protected]

MissionIR is powered by IBN

This entry was posted in SenesTech Inc. SNES. Bookmark the permalink.

Comments are closed.